Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study

EuroIntervention 2017;13:867-876 published online ahead of print June 2017. DOI: 10.4244/EIJ-D-17-00493

Ulf Landmesser
Ulf Landmesser1*, MD; Boris Schmidt2, MD; Jens Erik Nielsen-Kudsk3, MD, DMSc; Simon Cheung Chi Lam4, MD; Jai-Wun Park5, MD; Giuseppe Tarantini6, MD; Ignacio Cruz-Gonzalez7, MD, PhD; Volker Geist8, MD; Paolo Della Bella9, MD; Antonio Colombo9, MD; Tobias Zeus10, MD; Heyder Omran11, MD; Christopher Piorkowski12, MD; Juha Lund13, MD; Claudio Tondo14, MD, PhD; David Hildick-Smith15, MD; on behalf of the Amulet Observational Study Investigators
1. Department of Cardiology, Charité Universitätsmedizin Berlin (CBF); Berlin Institute of Health (BIH); German Center of Cardiovascular Research (DZHK), Berlin, Germany; 2. Cardioangiologisches Centrum Bethanien, Agaplesion Markus-Krankenhaus, Frankfurt,

Aims: The global, prospective AMPLATZER Amulet observational study documents real-world periprocedural, transoesophageal echocardiographic (TEE) and clinical outcomes from left atrial app

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

atrial fibrillationbleedingleft atrial appendage closurestroke
Interventions for strokeLAA closureTools, devices and techniques
Read next article
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry

Latest news